Dietary DHA/EPA supplementation ameliorates diabetic nephropathy by protecting from distal tubular cell damage

Cell Tissue Res. 2019 Nov;378(2):301-317. doi: 10.1007/s00441-019-03058-y. Epub 2019 Jun 29.

Abstract

The aim was to explore the influence of experimental diabetes mellitus type 1 (DM1) and potential protective/deleterious effects of different dietary n-6/n-3 PUFA ratios on renal phospholipid composition and pathological changes caused by DM1. Male Wistar rats were injected with 55 mg/kg streptozotocin or citrate buffer (control group). Control (C) and diabetic groups (STZ) were fed with n-6/n-3 ratio of ≈ 7, STZ + N6 with n-6/n-3 ratio ≈ 60 and STZ + DHA with n-6/n-3 ratio of ≈ 1 containing 16% EPA and 19% DHA. Tissues were harvested 30 days after DM1 induction. Blood and kidneys were collected and analysed for phospholipid fatty acid composition, pathohystological changes, ectopic lipid accumulation and expression of VEGF, NF-kB and special AT-rich sequence-binding protein-1 (SATB1). Pathological changes were studied also by using transmission electron microscopy, after immunostaining for VEGF. Substantial changes in renal phospholipid fatty acid composition resulted from DM1 and dietary PUFA manipulation. Extensive vacuolization of distal tubular cells (DTCs) was found in DM1, but it was attenuated in the STZ + DHA group, in which the highest renal NF-kB expression was observed. The ectopic lipid accumulation was observed in proximal tubular cells (PTCs) of all diabetic animals, but it was worsened in the STZ + N6 group. In DM1, we found disturbance of VEGF-transporting vesicular PTCs system, which was substantially worsened in STZ + DHA and STZ + N6. Results have shown that the early phase of DN is characterized with extent damage and vacuolization of DTCs, which could be attenuated by DHA/EPA supplementation. We concluded that dietary fatty acid composition can strongly influence the outcomes of DN.

Keywords: Diabetic nephropathy; Distal tubules; PUFA; SATB1; VEGF.

MeSH terms

  • Animals
  • Diabetes Mellitus, Experimental
  • Diabetes Mellitus, Type 1 / pathology*
  • Diabetic Nephropathies / metabolism*
  • Dietary Supplements
  • Docosahexaenoic Acids / pharmacology*
  • Eicosapentaenoic Acid / pharmacology*
  • Fatty Acids / metabolism
  • Homeodomain Proteins / metabolism
  • Kidney Tubules, Distal* / metabolism
  • Kidney Tubules, Distal* / pathology
  • Male
  • Phospholipids / metabolism
  • Rats
  • Rats, Wistar
  • Vascular Endothelial Growth Factor A / metabolism

Substances

  • Fatty Acids
  • Homeodomain Proteins
  • Phospholipids
  • SATB1 protein, rat
  • Vascular Endothelial Growth Factor A
  • Docosahexaenoic Acids
  • Eicosapentaenoic Acid